These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12647445)

  • 1. [Opinions about long-term treatment of schizophrenia among psychiatrist in Gdansk region].
    Gizińska D; Trzebiatowska IA
    Psychiatr Pol; 2002; 36(6 Suppl):243-8. PubMed ID: 12647445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of a Polish national survey--physician's opinions on the physical health of schizophrenic patients].
    Kiejna A; Czernikiewicz A; Adamowski T
    Psychiatr Pol; 2009; 43(6):761-73. PubMed ID: 20209887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring regional variation in antipsychotic coprescribing practice: a Danish questionnaire survey.
    Baandrup L; Allerup P; Nordentoft M; Lublin H; Glenthoj BY
    J Clin Psychiatry; 2010 Nov; 71(11):1457-64. PubMed ID: 21034689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
    Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
    Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to utilizing long-acting injectable antipsychotic medications.
    Getzen H; Beasley M; D'Mello DA
    Ann Clin Psychiatry; 2014 Feb; 26(1):33-8. PubMed ID: 24660225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to utilizing long-acting injectable antipsychotic medications.
    Getzen H; Beasley M; D'Mello DA
    Ann Clin Psychiatry; 2013 Nov; 25(4):E1-6. PubMed ID: 24199223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physicians' opinion on the use of perazine in the treatment of mental disorders--results of the Delphi consensus study].
    Adamowski T; Kiejna A
    Psychiatr Pol; 2012; 46(6):985-93. PubMed ID: 23479940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and organizational determinants of quality of care in patients with schizophrenia in Italy.
    Bollini P; Pampallona S; Tibaldi G; Bianco M; Nieddu S; Munizza C
    J Nerv Ment Dis; 2008 Dec; 196(12):923-6. PubMed ID: 19077861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing for inpatients with schizophrenia: an international multi-center comparative study.
    Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P
    Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How long should prophylactic antipsychotic therapy last after the initial schizophrenic psychosis?].
    Vlaminck P
    Ned Tijdschr Geneeskd; 1998 Sep; 142(39):2160-1. PubMed ID: 9856234
    [No Abstract]   [Full Text] [Related]  

  • 14. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
    Hamann J; Pfeiffer H; Leucht S; Kissling W
    Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia trial participation: perceived inclusion barriers and beliefs about antipsychotics.
    Ghio L; Natta W; Barbato A; Marcenaro M; Gotelli S; Jones PB; Parabiaghi A
    Pharmacopsychiatry; 2011 Jun; 44(4):123-8. PubMed ID: 21710401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?
    Hamann J; Mendel R; Heres S; Leucht S; Kissling W
    Eur Neuropsychopharmacol; 2010 Apr; 20(4):276-9. PubMed ID: 20133108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional antipsychotic prescription in unipolar depression, II: withdrawing conventional antipsychotics in unipolar, nonpsychotic patients.
    Mortimer AM; Martin M; Wheeler Vega JA; Tyson PJ
    J Clin Psychiatry; 2003 Jun; 64(6):668-72; quiz 738-9. PubMed ID: 12823081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of relapse in schizophrenia is discontinued too soon. Many colleagues make this mistake!].
    Seemann U; Kissling W
    MMW Fortschr Med; 2000 Feb; 142(5):34-8. PubMed ID: 10715937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.